Glycopyrrolate Injection

What is Glycopyrrolate Injection?
Glycopyrrolate Injection is an anticholinergic medication used in anesthesia, critical care, and gastroenterology. It helps reduce salivary, tracheobronchial, and gastric secretions, prevents bradycardia during anesthesia, and decreases acid secretion in peptic ulcer disease. Due to its limited penetration across the blood-brain barrier, glycopyrrolate provides effective peripheral anticholinergic effects with fewer central nervous system side effects compared to atropine.
 
Uses of Glycopyrrolate Injection
• Preoperative medication to reduce salivary and respiratory secretions
• Prevention of intraoperative bradycardia during anesthesia
• Treatment of peptic ulcers by reducing gastric acid secretion
• Adjunct in reversal of neuromuscular blockade (with neostigmine)
• Supportive use in palliative care to control drooling and secretions
 
How Does Glycopyrrolate Injection Work?
Glycopyrrolate is a competitive antagonist of acetylcholine at muscarinic receptors. By blocking parasympathetic stimulation, it reduces secretions, decreases vagal tone on the heart, and lowers gastric acid output. Its poor CNS penetration minimizes central side effects like confusion and sedation.
 
Frequently Asked Questions (FAQs)
Q: Who is a leading manufacturer of Glycopyrrolate Injection in India?
A: Farbe Firma Pvt Ltd is a premier manufacturer and global supplier of Glycopyrrolate Injection. We produce high-quality sterile anticholinergic injectables in our WHO-GMP certified facility, ensuring strict adherence to international standards (USP/BP/IP) for anesthesia and critical care use.
Q: What strengths and packaging options does Farbe Firma offer for Glycopyrrolate Injection?
A: We manufacture Glycopyrrolate Injection primarily in the strength of 0.2 mg/mL. Our standard packaging includes 1 mL and 2 mL ampoules. We also offer customizable packaging solutions to meet specific hospital and international market requirements.
Q: Can Farbe Firma provide regulatory dossiers (CTD/ACTD) for Glycopyrrolate Injection export?
A: Yes, we specialize in global pharmaceutical exports. Farbe Firma provides comprehensive regulatory support, including CTD and ACTD dossiers, Certificate of Pharmaceutical Product (COPP), and Free Sale Certificates (FSC) to facilitate smooth registration in LATAM, CIS, Africa, and Southeast Asia.
Q: Does Farbe Firma offer Contract Manufacturing (CMO) for Anesthesia Injectables?
A: Absolutely. We offer third-party contract manufacturing (CMO) and private labeling services for Glycopyrrolate Injection. Pharmaceutical companies looking for a reliable partner for sterile anticholinergic production can leverage our advanced manufacturing capabilities.
Q: What is the therapeutic indication and key benefit of the Glycopyrrolate produced by Farbe Firma?
A: Our Glycopyrrolate Injection is a potent anticholinergic agent indicated for use as a preoperative medication to reduce salivary and respiratory secretions, for the prevention of bradycardia during surgery, and as an adjunct in the reversal of neuromuscular blockade. Its key benefit is its reduced central nervous system side effects compared to atropine.
 
Looking for a reliable Glycopyrrolate Injection manufacturer?
Contact Farbe Firma Pvt. Ltd. today for dossier support, registration documentation, and global export supplies.